J Med Chem. 2010 Feb 11;53(3):1086-97.

Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancer.

Source

Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, USA. sutherlin.dan@gene.com

Abstract

The PI3K/AKT/mTOR pathway has been shown to play an important role in cancer. Starting with compounds 1 and 2 (GDC-0941) as templates, (thienopyrimidin-2-yl)aminopyrimidines were discovered as potent inhibitors of PI3K or both PI3K and mTOR. Structural information derived from PI3K gamma-ligand cocrystal structures of 1 and 2 were used to design inhibitors that maintained potency for PI3K yet improved metabolic stability and oral bioavailability relative to 1. The addition of a single methyl group to the optimized 5 resulted in 21, which had significantly reduced potency for mTOR. The lead compounds 5 (GNE-493) and 21 (GNE-490) have good pharmacokinetic (PK) parameters, are highly selective, demonstrate knock down of pathway markers in vivo, and are efficacious in xenograft models where the PI3K pathway is deregulated. Both compounds were compared in a PI3K alpha mutated MCF7.1 xenograft model and were found to have equivalent efficacy when normalized for exposure.

PMID:: 20050669; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Chemical Information

BindingDB

Molecular Biology Databases

THIOPHENE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor. [Bioorg Med Chem Lett. 2010]
Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor.
Heffron TP, Berry M, Castanedo G, Chang C, Chuckowree I, Dotson J, Folkes A, Gunzner J, Lesnick JD, Lewis C, et al. Bioorg Med Chem Lett. 2010 Apr 15; 20(8):2408-11. Epub 2010 Mar 12.
Lead optimization of N-3-substituted 7-morpholinotriazolopyrimidines as dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitors: discovery of PKI-402. [J Med Chem. 2010]
Lead optimization of N-3-substituted 7-morpholinotriazolopyrimidines as dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitors: discovery of PKI-402.
Dehnhardt CM, Venkatesan AM, Delos Santos E, Chen Z, Santos O, Ayral-Kaloustian S, Brooijmans N, Mallon R, Hollander I, Feldberg L, et al. J Med Chem. 2010 Jan 28; 53(2):798-810.
Antitumor efficacy profile of PKI-402, a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor. [Mol Cancer Ther. 2010]
Antitumor efficacy profile of PKI-402, a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.
Mallon R, Hollander I, Feldberg L, Lucas J, Soloveva V, Venkatesan A, Dehnhardt C, Delos Santos E, Chen Z, Dos Santos O, et al. Mol Cancer Ther. 2010 Apr; 9(4):976-84. Epub 2010 Apr 6.
Review Advances in development of phosphatidylinositol 3-kinase inhibitors. [Curr Med Chem. 2009]
Review Advances in development of phosphatidylinositol 3-kinase inhibitors.
Kong D, Yamori T. Curr Med Chem. 2009; 16(22):2839-54.
Review Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia. [Expert Opin Investig Drugs. 2009]
Review Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia.
Martelli AM, Evangelisti C, Chiarini F, Grimaldi C, Manzoli L, McCubrey JA. Expert Opin Investig Drugs. 2009 Sep; 18(9):1333-49.

See reviews... See all...

Structures reported by this article

Discovery Of (Thienopyrimidin-2-Yl)aminopyrimidines As Potent, Selective, And Orally Available Pan-Pi3-Kinase And Dual Pan-Pi3-KinaseMTOR INHIBITORS FOR THE TREATMENT OF Cancer

PDB: 3L17

Source: Homo sapiens

Method: X-Ray Diffraction

Resolution: 3 Å

See all 3 structures...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
BioAssay
PubChem BioAssay experiments on the biological activities of small molecules that cite the current articles. The depositors of BioAssay data provide these references.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Taxonomy via GenBank
Taxonomy records associated with the current articles through taxonomic information on related molecular database records (Nucleotide, Protein, Gene, SNP, Structure).
Protein
Protein translation features of primary database (GenBank) nucleotide records reported in the current articles as well as Reference Sequences (RefSeqs) that include the articles as references.
Structure
Three-dimensional structure records in the NCBI Structure database for data reported in the current articles.

Recent activity

Clear Turn Off Turn On

Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and or...
Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancer.
J Med Chem. 2010 Feb 11 ;53(3):1086-97.

PubMed
Screening for adolescent depression: a comparison of depression scales.
Screening for adolescent depression: a comparison of depression scales.
J Am Acad Child Adolesc Psychiatry. 1991 Jan ;30(1):58-66.

PubMed
Mental health service use by adolescents in the 1970s and 1980s.
Mental health service use by adolescents in the 1970s and 1980s.
J Am Acad Child Adolesc Psychiatry. 1991 Jan ;30(1):144-50.

PubMed
Calculating skill mix: implications for patient outcomes and costs.
Calculating skill mix: implications for patient outcomes and costs.
Nurs Manag (Harrow). 2009 Dec ;16(8):22-3.

PubMed
The Child Behavior Checklist nonclinical standardization samples: should they be...
The Child Behavior Checklist nonclinical standardization samples: should they be utilized as norms?
J Am Acad Child Adolesc Psychiatry. 1991 Jan ;30(1):124-34.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: